COMPARISON OF STRATIFIED WEIBULL MODEL AND WEIBULL ACCELERATED FAILURE TIME (AFT) MODEL IN THE ANALYSIS OF CERVICAL CANCER SURVIVAL

Authors

  • Nurliyana Juhan Preparatory Centre for Science and Technology, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia
  • Nuradhiathy Abd Razak Graduate Studies, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • Yong Zulina Zubairi Centre for Foundation Studies in Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
  • Nyi Nyi Naing Unit of Biostatistics and Research Methodology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kelantan, Malaysia
  • Che Haziqah Che Hussin Preparatory Centre for Science and Technology, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia
  • Muhamad Azlan Daud Preparatory Centre for Science and Technology, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.11113/jt.v78.8970

Keywords:

Accelerated Failure Time (AFT), cervical cancer, prognostic factor, stratified weibull, survival

Abstract

Cervical cancer is the fourth most common cancer affecting women worldwide, after breast, colorectal, and lung cancers with 528 000 new cases every year. It is also the fourth most common cause of cancer death with 266 000 deaths in 2012 among women worldwide. In Malaysia it remains to be a great concern among clinicians; yet published works on survival of cervical cancer patients are somewhat limited. In this study, two survival regression models which are parametric Stratified Weibull model and Weibull Accelerated Failure Time (AFT) model are considered as the alternative and improvement of the well-known Cox proportional hazard model to evaluate the prognostic factor that effect on survival of patients with cervical cancer. Comparisons were made to find the best model. Data were taken from Hospital University Science Malaysia (HUSM) over a period of 12 years. From the analyses it was found that the AFT model was the most appropriate. The AFT model has shown that the median survival time for patient at stage III & IV (14 months) is about one third that of those at stages I & II (40 months) for the same distant metastasis group. While, the median survival time for patient with distant metastasis (17 months) is half that of those without distant metastasis (34 months) for the same stage group.

References

Ferlay, J., I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, F. Bray. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon. France: International Agency for Research on Cancer. [Online]. From: http://globocan.iarc.fr, accessed on day/month/year. [Accessed on 5 December 2014].

Bray, F., J. S. Ren, E. Masuyer, J. Ferlay. 2013. Global Estimates Of Cancer Prevalence For 27 Sites In The Adult Population In 2008. Int J Cancer. 132(5): 1133-1145.

Berrington de Gonzalez, A. 2007. Comparison Of Risk Factors For Invasive Squamous Cell Carcinoma And Adenocarcinoma Of The Cervix: Collaborative Reanalysis Of Individual Data On 8,097 Women With Squamous Cell Carcinoma And 1,374 Women With Adenocarcinoma From 12 Epidemiological Studies. International Journal of Cancer. 120(4): 885-889.

Omar, Z. A., N. Ibrahim. 2011. National Cancer Registry Report 2007. Malaysia Cancer Statistics-Data and Figure. Kuala Lumpur: National Cancer Registry, Ministry of Health Malaysia.

Domingo, E. J., R. Noviani, M. R. Noor, C. A. Ngelangel, K. K. Limpaphayom, T. V. Thuan. 2008. Epidemiology And Prevention Of Cervical Cancer In Indonesia, Malaysia, The Philippines, Thailand And Vietnam. Vaccine. 26(12): 71-79.

Talbäck, M., M. Stenbeck, M. Rosén. 2004. Up-To-Date Long-Term Survival Of Cancer Patients: An Evaluation Of Period Analysis On Swedish Cancer Registry Data. Eur J Cancer. 40: 1361-1372.

Pomros, P., S. Sriamporn, V. Tangvoraphonkchai, S. Kamsa-Ard, K. Poomphakwaen. 2007. Factors Affecting Survival Of Cervical Cancer Patients Treated At The Radiation Unit Of Srinagarind Hospital, Khon Kaen University, Thailand. Asian Pac J Cancer Prev. 8: 297-300.

Ho, K. C., C. C. Wang, J. T. Qiu, C. H. Lai, J. H. Hong, Y. T. Huang. 2011. Identification Of Prognostic Factors In Patients With Cervical Cancer And Supraclavicular Lymph Node Recurrence. Gynecol Oncol. 123(2): 253-256.

Kim, T. E., B. J. Park, H. S. Kwack, J. Y. Kwon, J. H. Kim, S. C. Yoon. 2012. Outcomes And Prognostic Factors Of Cervical Cancer After Concurrent Chemoradiation. J Obstet Gynaecol Res. 38(11): 1315-1320.

Kleinbaum, D. G. 1995. Survival Analysis-A Self-Learning Text. New York: Springer-Verlag.

Pourhoseingholi, M. A., E. Hajizadeh, B. M. Dehkordi, A. Safaee, A. Abadi, M. R. Zali. 2007. Comparing Cox Regression And Parametric Models For Survival Of Patients With Gastric Carcinoma. Asian Pac J Cancer Prev. 8: 412-416.

Moghimi-Dehkordi, B. A., Safaee, M. A. Pourhoseingholi, R. Fatemi, Z. Tabeie, M. R. Zali. 2008. Statistical Comparison Of Survival Models For Analysis Of Cancer Data. Asian Pacific J Cancer Prev. 9: 417-420.

Ding, S., S. J. Soong, H. Y. Lin, R. Desmond, C. M. Balch. 2009. Parametric Modeling Of Localized Melanoma Prognosis And Outcome. J Biopharm Statistics. 19: 732-747.

Nakhaee, F., M. Law. 2011. Parametric Modelling Of Survival Following HIV And AIDS In The Era Of Highly Active Antiretroviral Therapy: Data From Australia. East Mediterr Health. 17(3): 231-237.

Ravangard, R., M. Arab, A. Rashidian, A. Akbarisari, A. Zare, H. Zeraati. 2011. Comparison Of The Results Of Cox Proportional Hazards Model And Parametric Models In The Study Of Length Of Stay In A Tertiary Teaching Hospital In Tehran, Iran. Acta Med Iran. 49(10): 650-658.

Zhu, H. P., X. Xia, C. H. Yu, A. Adnan, S. F. Liu, Y. K. Du. 2011. Application Of Weibull Model For Survival Of Patients With Gastric Cancer. BMC Gastroenterology. 11: 1.

Therneau, T. M., P. M. Grambsch. 2000. Modeling Survival Data. Statistics for Biology and Health. New York: Springer-Verlag.

Dueňas-González, A., M. Orlando, Y. Zhou, M. Quinlivan, H. Barraclough. 2012. Efficacy Inhigh Burden Locally Advanced Cervical Cancer With Concurrent Gemcitabine And Cisplatin Chemoradiotherapy Plus Adjuvant Gemcitabine And Cisplatin: Prognostic And Predictive Factors And The Impact Of Disease Stage On Outcomes From A Prospective Randomized Phase III Trial. Gynecol Oncol. 126: 334-340.

Monk, B. J., C. Tian, P. G. Rose, R. Lanciano. 2007. Which Clinical/Pathologic Factors Matter In The Era Of Chemoradiation As Treatment For Locally Advanced Cervical Carcinoma? Analysis Of Two Gynecologic Oncology Group (GOG) Trials. Gynecol Oncol. 105: 427-433.

Juhan, N., N. Abd Razak, Y. Z. Zubairi, M. N. Khattak, N. N. Naing. 2013. Survey of Patients with Cervical Cancer in Hospital Universiti Sains Malaysia: Survival Data Analysis with Time-Dependent Covariate. Iranian Jornal of Public Health. 42: 980-987.

Chen, J., O. K. Macdonald, D. K. Gaffney. 2008. Incidence, Mortality, And Prognostic Factors Of Small Cell Carcinoma Of The Cervix. Obstet Gynecol. 111: 1394-1402.

Wang, K. L., T. C. Chang, S. M. Jung, C. H. Chen, Y. M. Cheng, H. H. Wu. 2012. Primary Treatment And Prognostic Factors Of Small Cell Neuroendocrine Carcinoma Of The Uterine Cervix: A Taiwanese Gynecologic Oncology Group Study. Eur J Cancer. 48: 1484-1494.

Downloads

Published

2016-06-12

How to Cite

COMPARISON OF STRATIFIED WEIBULL MODEL AND WEIBULL ACCELERATED FAILURE TIME (AFT) MODEL IN THE ANALYSIS OF CERVICAL CANCER SURVIVAL. (2016). Jurnal Teknologi, 78(6-4). https://doi.org/10.11113/jt.v78.8970